Foley Hoag Represents Alere Inc. in $60M Acquisition of US Diagnostics

July 27, 2015

Foley Hoag LLP recently represented Alere Inc. (NYSE: ALR) in its acquisition of substantially all of the assets of US Diagnostics for $60 million in cash. US Diagnostics, based in Huntsville, Alabama, is a provider of drug testing devices and a distributor of Alere Toxicology products. Alere plans to use the transaction to provide access to an expanded customer base with additional opportunities for selling other Alere Toxicology solutions and other business synergies.

Headquartered in Waltham, Mass., Alere focuses on rapid diagnostics for infectious disease, cardiometabolic disease and toxicology.

Foley Hoag attorneys Mark Haddad, Erin Klein, James Schneider and Jeremy Arak represented Alere in the transaction.

About Foley Hoag LLP

Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and investment management fields, and in cross-border disputes. Our professionals  possess the skills  and experience to provide exceptional senior level service to clients ranging from startups to multinational companies to sovereign states. For more information, visit www.foleyhoag.com or follow @FoleyHoag on Twitter.